Gastrointestinal Diseases Clinical Trial
Official title:
Propofol Versus Midazolam in Sedation for Upper and Lower Gastrointestinal Endoscopy.
There has been rapid growth in the number and complexity of gastrointestinal (GI) endoscopic procedures performed during the last decade. To ensure safe and effective upper GI endoscopy, the choice of an appropriate sedative agent is crucial. Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal [GI] endoscopy usually performed under moderate sedation Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal [GI] endoscopy usually performed under moderate sedation. Benzodiazepines still the most common sedative agents used for conscious sedation, either solely or in combination with opioids for upper GI endoscopy. Propofol is a hypnotic drug used for induction of anesthesia with short half-life that permits rapid patient recovery and discharge. Thus, its use is for upper GI endoscopy was adopted in many endoscopy centers. So we are going to Evaluate all adverse events related to anesthesia; in patients recruited for upper and lower endoscopy and compare between propofol and midazolam based anesthesia associated adverse events.Also we are going to Evaluate patient and endoscopist satisfaction as regarding propofol and midazolam anesthesia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02541357 -
Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
|
N/A | |
| Active, not recruiting |
NCT02358122 -
Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh
|
N/A | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Enrolling by invitation |
NCT00943345 -
Validation of New Tests for Gastrointestinal (GI) Permeability
|
Phase 0 | |
| Completed |
NCT00612404 -
Symptoms and Endoscopic Results in Consideration of Pretreatment
|
N/A | |
| Completed |
NCT01127711 -
Cohort of Swedish Men
|
N/A | |
| Recruiting |
NCT05712525 -
Gut Recovery In Patients Following Surgery
|
||
| Recruiting |
NCT06094153 -
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
|
N/A | |
| Recruiting |
NCT05322486 -
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
|
||
| Completed |
NCT02486146 -
GI Biorepository of Tissue and Bodily Fluids
|
N/A | |
| Completed |
NCT01816607 -
Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
|
||
| Completed |
NCT00247715 -
Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
|
N/A | |
| Completed |
NCT00035334 -
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06286865 -
Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial
|
N/A | |
| Active, not recruiting |
NCT01037049 -
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
|
Phase 2 | |
| Completed |
NCT03725813 -
Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit
|
N/A | |
| Recruiting |
NCT05640401 -
Holographic Screens as a Replacement of Monitors During GI Endoscopies
|
N/A | |
| Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
| Completed |
NCT02651857 -
Exploratory Study of Upper and Lower Endoscopic Fuse System
|
N/A | |
| Active, not recruiting |
NCT01984034 -
Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines
|
N/A |